Concepedia

Advanced Glycation End Products in the Development of Ischemic and Dilated Cardiomyopathy in Patients With Diabetes Mellitus Type 2

Jerzy Nożyński, Michał Zakliczyńśki, D. Konecka-Mrówká, Barbara Nikiel, Joanna Młynarczyk-Liszka, Ewa Zembala‐Nożyńska, Dariusz Lange, Marcin Maruszewski, Marian Zembala

Transplantation Proceedings · 2009 · 12 citations · 29 references

DOI

Concepts

References

29

Aminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-Linking

M. Brownlee, Helen Vlassara, A. Kooney et al. · Science · 1986 · 1.1K citations

, , +15

Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

Erwin Schleicher, Ernst Wagner · Journal of Clinical Investigation · 1997 · 712 citations · Full text

, , +14

Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease.

Bente Kilhovd, Tore Julsrud Berg, K. I. Birkeland et al. · Diabetes Care · 1999 · 268 citations

, , +10

The breakdown of pre‐existing advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes

Josephine M. Forbes, Vicki Thallas, Merlin C. Thomas et al. · The FASEB Journal · 2003 · 266 citations

, , +17

Receptor for Advanced-Glycation End Products

Loredana Bucciarelli, Michiyo Kaneko, Radha Ananthakrishnan et al. · Circulation · 2006 · 250 citations · Full text

, , +15